David Spiegel

Overview

David Spiegel is the Stanford psychiatrist and clinical hypnosis researcher interviewed by Andrew Huberman about focused attention, mind-body regulation, pain, stress, sleep, trauma, and self-hypnosis.

Current Profile

The source presents Spiegel as a clinician-researcher who treats hypnosis as a learnable use of attention rather than entertainment or surrender of control. His organizing principle is agency: a person voluntarily narrows attention, changes bodily state, approaches a defined problem, and practices entering and leaving the state. He connects that clinical model to imaging research, randomized trials, and decades of work with pain, phobias, trauma, grief, insomnia, medical procedures, and support groups.

Spiegel also maintains a clear treatment boundary. He recommends providers licensed in a primary health discipline, warns against hypnotically suppressing symptoms before medical causes are evaluated, and describes many applications as dependent on Hypnotizability. His discussion distinguishes established clinical use from open questions about ADHD, OCD, EMDR mechanisms, medication adjuncts, and long-term neural change.

Key Characteristics

• Defines hypnosis as focused absorption that can increase voluntary mind-body control.
• Uses problem-focused exercises combining imagery, bodily calm, and cognitive reframing.
• Studies neural correlates and individual differences in hypnotic response.
• Applies hypnosis to selected pain, stress, sleep, trauma, grief, fear, and procedure contexts.
• Favors brief clinician-guided teaching followed by self-hypnosis practice when appropriate.
• Emphasizes licensed care, medical screening, and limits on unsupported generalization.

Evidence

• Clinical framework - Using Hypnosis to Enhance Mental & Physical Health & Performance | Dr. David Spiegel describes focused attention, bodily regulation, imagined exposure, and agency as core elements.
• Research program - Using Hypnosis to Enhance Mental & Physical Health & Performance | Dr. David Spiegel reports imaging, pain, cancer-support, PTSD, and pediatric-procedure research associated with Spiegel.
• Individual differences - Using Hypnosis to Enhance Mental & Physical Health & Performance | Dr. David Spiegel presents hypnotizability as a stable capacity that influences treatment response.
• Safety boundary - Using Hypnosis to Enhance Mental & Physical Health & Performance | Dr. David Spiegel recommends trained licensed professionals and prior assessment of potentially serious symptoms.
• Translation - Using Hypnosis to Enhance Mental & Physical Health & Performance | Dr. David Spiegel identifies Reveri and professional hypnosis societies as routes for practice or referral.

Qualifications

This profile is based on one condensed public interview rather than an independent review of Spiegel’s complete research record. The reported effect sizes, brain-network interpretations, eye-roll test, GABA association, medication interactions, and comparative claims about EMDR remain source-scoped. Clinical hypnosis is not presented as universally effective or as a substitute for diagnosis, emergency care, trauma-informed treatment, or individualized medical advice.

What Changed

• Created the profile to capture Spiegel’s control-centered clinical hypnosis model, research program, and safety boundaries.

Relationships

• Andrew Huberman - interviewer who connects Spiegel’s clinical account to attention, breathing, sleep, and performance.
• Huberman Lab - program hosting the current source.
• Clinical Hypnosis - principal clinical method and research focus in the profile.
• Hypnotizability - individual-difference construct conditioning response to the method.
• Reveri - self-hypnosis product derived from Spiegel’s research program.
• Trauma Narrative Integration / 创伤叙事整合 - adjacent trauma process centered on voluntary approach, meaning, and restored agency.
• Memory Contamination Risk - caution against equating vivid or state-accessible recall with verified accuracy.